Despite the wide use of clock drawing tests (CDTs) for screening cognitive impairment, their use in patients having Parkinson disease (PD) with dementia has not been systematically investigated until date. In this cross-sectional study, neurological and neuropsychiatric statuses of 1449 outpatients having PD with and without dementia were comprehensively assessed. The CDT revealed cognitive impairment in 42.7% of the 1383 patients whose drawings were available. Overall, CDT sensitivity and specificity were 70.7% and 68.9%, respectively. The positive and negative predictive values were 48.0% and 85.3%, respectively. In patients with depression, CDT specificity dropped significantly to 55.8% (71.3% in nondepressed patients, P < .001). Classification performance was not impacted by motor symptoms. The estimated classification performances and predictive values correspond to those reported previously for non-PD populations. Our results indicate that CDT is a suitable screening instrument in patients with PD, but test results from patients with depression warrant careful consideration.
LorentzWScanclanJBorsonS. Brief screening tests for dementia. Can J Psychiatry. 2002;47(8):723–733.
2.
MalloyPFCummingsJLCoffeyCECognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1997;9(2):189–197.
3.
ShulmanK. Clock-drawing: is it the ideal cognitive screening test?Int J Geriatr Psychiatry. 2000;15(6):548–561.
4.
SunderlandTHillJLMellowAMClock drawing in Alzheimer’s disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37(8):725–729.
5.
WatsonYIArfkenCLBirgeSJ. Clock completion—an objective screening-test for dementia. J Am Geriatr Soc. 1993;41(11):1235–1240.
6.
HeinikJSolomeshILinRClock drawing test-modified and integrated approach (CDT-MIA): description and preliminary examination of its validity and reliability in dementia patients referred to a specialized psychogeriatric setting. J Geriatr Psychiatry Neurol. 2004;17(2):73–80.
7.
NasreddineZSPhillipsNABedirianVThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
8.
CritchleyM. The Parietal Lobes. New York, NY: Hafner Publishing Company; 1966.
9.
BozikasVPKosmidisMHKourtisAClock drawing test in institutionalized patients with schizophrenia compared with Alzheimer's disease patients. Schizophr Res. 2003;59(2-3):173–179.
10.
BrodatyHMooreCM. The clock drawing test for dementia of the Alzheimer's type: a comparison of three scoring methods in a memory disorders clinic. Int J Geriatr Psychiatry. 1997;12(6):619–627.
11.
IsmailZRajjiTKShulmanKI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry. 2010;25(2):111–120.
12.
SakaEElibolB. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction. Parkinsonism Relat Disord. 2009;15(9):688–691.
13.
FukuiTLeeE. Visuospatial function is a significant contributor to functional status in patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2009;24(4):313–321.
14.
CormackFAarslandDBallardCToveeM.Pentagon drawing and neuropsychological performance in Dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry. 2004;19(4):371–377.
15.
NagahamaYOkinaTSuzukiNMatsudaM. Cerebral substrates related to impaired performance in the clock-drawing test in dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2008;25(6):524–530.
16.
PerneczkyRDrzezgaABoeckerHMetabolic alterations associated with impaired clock drawing in Lewy body dementia. Psychiatry Res. 2010;181(2):85–89.
17.
RiedelOKlotscheJSpottkeACognitive impairment in 873 patients with idiopathic Parkinson's disease: results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol. 2008;255(2):255–264.
18.
RiedelOKlotscheJSpottkeAFrequency of dementia, depression and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol. 2010;257(7):1073–1082.
HoehnMYahrM. Parkinsonism: onset, progression and mortality. Neurology1967;17(5):427–442.
21.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders—Text Revision. 4th ed. Washington, DC: American Psychiatric Association; 2000.
22.
ZaudigMHillerWGeiselmannBSIDAM—Strukturiertes Interview für die Diagnose einer Demenz vom Alzheimer Typ, der Multiinfarkt-(oder vaskulären) Demenz und Demnzen anderer Ätiologien nach DSM-III-R, DSM-IV und ICD-10. Göttingen, Germany: Hogrefe; 1996.
23.
FolsteinMFolsteinSMcHughP. Mini-Mental state: a practical method for grading the mental state of patients by the clinician. J Psychiatr Res. 1975;12(3):189–198.
24.
NishiwakiYBreezeESmeethLBulpittCPetersRFletcherA. Validity of the clock-drawing-test as a screening tool for cognitive Impairment in the elderly. Am J Epidemiol. 2004;160(8):797–807.
25.
MontgomerySAsbergM. A new depression scale, designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
26.
LeentjensAVerheyFLousbergRSpitsbergenHWilminkF. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. 2000;15(7):644–649.
27.
RiedelOHeuserIKlotscheJDodelRWittchenH-U. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD study. J Geriatr Psychiatry Neurol. 2010;23(1):27–34.
28.
ShulmanKIGoldDPCohenCAZuccheroCA. Clock drawing and dementia in the community—a longitudinal study. Int J Geriatr Psychiatry. 1993;8:487–496.
29.
ClopperCJPearsonSE. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404–413.
30.
RoyallRM. Model robust confidence intervals using maximum likelihood estimators. Int Stat Rev. 1986;54(2):221–226.
SeigerschmidtEMöschESiemenMFörstlHBickelH. The clock drawing test and questionable dementia: reliability and validity. Int J Geriatr Psychiatry. 2002;17(11):1048–1054.
33.
HubbardEJSantiniVBlankevoortCGClock drawing performance in cognitively normal elderly. Arch Clin Neuropsychol. 2008;23(3):295–327.
